Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort StudyStéphanie Forté, Kevin H.M. Kuo, Dalton Budhram et al.|Journal of Clinical Medicine|2022Cited by 14
The rationale for abandoning sickle trait screening of red blood cell units for patients with sickle cell diseaseJohn Aneke, Christine Cserti‐Gazdewich, David Barth et al.|Transfusion Medicine|2019Cited by 7
Novel High Oxygen Affinity Hemoglobin Variant in a Patient with Polycythemia: Hb Kennisis [β85(F1)Phe→Leu (TT<i>T</i>>TT<i>G</i>); <i>HBB</i>: c.258T>G]Ibrahim Al Nabhani, John S. Waye, John Aneke et al.|Hemoglobin|2020Cited by 3
Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?Stéphanie Forté, Kevin H.M. Kuo, Shivani Bhat et al.|Blood|2018Cited by 2